Search
Olipudase alfa
go.drugbank.com/drugs/DB12835ApprovedInvestigational[A251590] It was later approved by the European Commission on June 28, 2022 [L42740] and by the FDA on August 31, 2022.[L43145] … [A251590] Olipudase alfa gained its first global approval in Japan on March 28, 2022.
Flurandrenolide
go.drugbank.com/drugs/DB00846ApprovedA corticosteroid used topically in the treatment of various skin disorders. It is usually employed as a cream or an ointment, and is also used as a polyethylene tape with an adhesive.
Lactulose
go.drugbank.com/drugs/DB00581ApprovedInvestigationalor refuted via clinical investigation. … Organization's List of Essential Medicines as one of the most effective and safe medicines employed in a health system[L6205], data regarding its optimal place in therapy is often ambiguous.
Synonyms: 4-O-beta-D-Galactopyranosyl-D-fructose, 4-O-beta-D-Galactopyranosyl-D-fructofuranoseProducts: LACTUNOVA JARABE 667 MG/ML, PMS-LACTULOSE SYRUP 667 mg/mlAmphotericin B
go.drugbank.com/drugs/DB00681ApprovedInvestigationalAmphotericin B shows a high order of in vitro activity against many species of fungi. … The antibiotic is without effect on bacteria, rickettsiae, and viruses.
Categories: Compounds used in a research, industrial, or household settingProducts: .® 1 MG/ML., Amphotec 50 mgPonesimod
go.drugbank.com/drugs/DB12016ApprovedInvestigationalPonesimod is a selective sphingosine 1-phosphate receptor 1 modulator indicated in the treatment of relapsing forms of multiple sclerosis in adults. … [A232079,L32709] Ponesimod was developed out of a need for a more selective modulator of sphingosine 1-phosphate receptor 1 than [fingolimod].
Umeclidinium
go.drugbank.com/drugs/DB09076ApprovedInvestigational[A7715] Maintenance of the airway is controlled by the parasympathetic nervous system, particularly by the abundance of the muscarinic subtype 3 (M3) in the airway smooth muscle. … COPD is a progressive obstructive lung disease characterized by shortness of breath, cough, sputum production, and chronically poor airflow with a forced expiratory volume in 1 second (FEV1) of less than
Products: FILIPIKA 62.5 MG, INCRUSE ELLIPTA 62.5 MG KULLANIMA HAZIR İNHALASYON TOZU, 30 DOZPalmitic Acid
go.drugbank.com/drugs/DB03796ApprovedInvestigationalA common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.
Mixtures: Levovist - Pws IV (4g Granules /vial)Setoperone
go.drugbank.com/drugs/DB20520ExperimentalSetoperone has a monoisotopic molecular weight of 401.16 Da. … The usage of the INN stem '-perone' in the name indicates that Setoperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.
Categories: Diagnostic Uses of Chemicals, Compounds used in a research, industrial, or household settingCapsicum oleoresin
go.drugbank.com/drugs/DB11131ApprovedThe intensity of biological actions and toxicological effects of capsicum oleoresin are a direct function of the amount of capsaicinoids, or capsaicin, present in the compound [L1944]. … for management of different models of neuropathic pain [A32316].
Synonyms: Oleoresins of capsicumBNT162B2 Omicron (LP.8.1)
go.drugbank.com/drugs/DB23337Approved[L53723] It encodes the spike protein from the Omicron LP.8.1 subvariant of SARS-CoV-2.[L53723] The 2025-2026 formulation of Pfizer-BioNTech's Comirnaty was approved by the US FDA in August 2025. … BNT162B2 Omicron (LP.8.1) is the active ingredient in the 2025-2026 formulation of Pfizer and BioNTech's Comirnaty mRNA vaccine for COVID-19.